SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001512977-11-000004
Filing Date
2011-02-15
Accepted
2011-02-15 09:52:23
Documents
1
Period of Report
2010-12-10

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 2956
  Complete submission text file 0001512977-11-000004.txt   4916
Mailing Address 101 COLLEGE STREET SUITE 220 TORONTO A6 M5G 1L7
Business Address 101 COLLEGE STREET SUITE 220 TORONTO A6 M5G 1L7 416-260-7770
Transition Therapeutics Inc. (Issuer) CIK: 0001399250 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0630
SIC: 2833 Medicinal Chemicals & Botanical Products
Office of Life Sciences

Mailing Address 28161 N. KEITH DRIVE LAKE FOREST IL 60045
Business Address 28161 N. KEITH DRIVE LAKE FOREST IL 60045 847.607.2066
Schuler Family Foundation (Reporting) CIK: 0001512977 (see all company filings)

State of Incorp.: IL | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-33514 | Film No.: 11612660